The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls
Open accessAbstract
Background: Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene—many of which cause cystic fibrosis—have also been reported in patients with chronic pancreatitis. The authors examine whether mild or severe CFTR mutations, homozygous or compound heterozygous CFTR mutations, or even simple cystic fibrosis carrier status alone increases the risk of developing pancreatitis. Methods: After exclusion of patients with trypsinogen (PRSS1) mutations, cystic fibrosis, or pulmonary disease, and with known risk factors for pancreatitis 67 patients with idiopathic chronic pancreatitis (ICP) from northwest Germany and 60 geographically and ethnically matched controls were recruited. The entire coding region of the CFTR gene was sequenced in all patients and controls. ICP patients were also analysed for serine protease inhibitor Kazal type 1 (SPINK1) gene mutations. Results: Abnormal CFTR alleles were found to be twice as frequent in ICP patients as in controls (25/134 v 11/120; p<0.05). Three of four severe CFTR mutations detected in patients were compound heterozygous with another abnormal CFTR allele, whereas among controls three severe CFTR mutations were found in heterozygous cystic fibrosis carriers. In ICP patients 19 uncommon/mild mutations, including combinations of the 5T allele with 12TG repeats, were identified compared with only five in controls (p = 0.012). Heterozygous SPINK1 mutations were detected in eight ICP patients (15% v 1% in controls) but only one also carried an additional mild CFTR mutation. Conclusions: These data show that not only compound heterozygosity, but also cystic fibrosis carrier status for different types of CFTR mutations, including uncommon/mild mutations, significantly increase the risk of developing pancreatitis. Although 45% of the study’s ICP patients carried predisposing genetic risk factors (for example, mutations in CFTR or SPINK1), the authors found no evidence that the risk conveyed by CFTR mutations depends on co-inherited SPINK1 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
Cited by
Genetics, Cell Biology, and Pathophysiology of Pancreatitis
Mayerle, J., Sendler, M., Hegyi, E., Beyer, G., Lerch, M. M., & Sahin-Tóth, M. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.081 · Cited by 375
Self-citationClan Genomics and the Complex Architecture of Human Disease
Lupski, J. R., Belmont, J. W., Boerwinkle, E., & Gibbs, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.008 · Cited by 370
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Becker, A. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11182 · Cited by 327
Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis
Ooi, C. Y., Dorfman, R., Cipolli, M., Gonska, T., Castellani, C., Keenan, K., Freedman, S. D., Zielenski, J., Berthiaume, Y., Corey, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.046 · Cited by 254
Metadata
- Authors
- Weiss, F. U., Simon, P., Bogdanova, N., Mayerle, J., Dworniczak, B., Horst, J., & Lerch, M. M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-06-29
- Volume
- 54
- Issue
- 10
- Pages
- 1456-1460
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2148399428
- Cited by
- 159
- References
- 1
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. https://app.cochat.ai/papers/10.1136/gut.2005.064808
- The paper
- Weiss, F. U., Simon, P., Bogdanova, N., Mayerle, J., Dworniczak, B., Horst, J., & Lerch, M. M. (2005). Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut. https://doi.org/10.1136/gut.2005.064808
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.